Tech Company Financing Transactions
NeuroKaire Funding Round
On 12/17/2024, NeuroKaire secured $10 million in funding from GreyBird Ventures, Jumpspeed Ventures and Meron Capital.
Transaction Overview
Company Name
Announced On
12/17/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to scale operations and further expand pharmaceutical partnerships.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Kearny, NJ Undisclosed
USA
Kearny, NJ Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
NeuroKaire, a Kearny, NJ-based biotechnology company specializing in precision medicine in psychiatry and neurology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Talia Solal
Browse more venture capital transactions:
Prev: 12/17/2024: Databricks venture capital transaction
Next: 12/17/2024: TG0 venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs